Oligonucleotide API Market Projected to Reach $5,184.2 Million by 2030
The latest market report published by Credence Research, Inc. The global demand for Oligonucleotide API was valued at USD 2315.5 million in 2022 and is expected to reach USD 5184.2 Million in 2030, growing at a CAGR of 10.60% between 2023 and 2030. The Oligonucleotide Active Pharmaceutical Ingredient (API) market has been rapidly expanding in recent years, reshaping the pharmaceutical landscape. Oligonucleotides are short sequences of nucleic acids that have gained significant attention due to their potential in treating a wide range of diseases, including genetic disorders, cancers, and viral infections. This article explores the dynamics of the Oligonucleotide API market, its growth drivers, and its crucial role in the future of medicine. Market Growth and Potential The Oligonucleotide API market has witnessed substantial growth, driven by the increasing understanding of the role of genetic information in diseases and advancements in biotechnology. Oligonucle...